Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 5
2015 17
2016 19
2017 20
2018 17
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Huntington's disease: a clinical review.
McColgan P, Tabrizi SJ. McColgan P, et al. Eur J Neurol. 2018 Jan;25(1):24-34. doi: 10.1111/ene.13413. Epub 2017 Sep 22. Eur J Neurol. 2018. PMID: 28817209 Review.
Clinical Features of Huntington's Disease.
Ghosh R, Tabrizi SJ. Ghosh R, et al. Adv Exp Med Biol. 2018;1049:1-28. doi: 10.1007/978-3-319-71779-1_1. Adv Exp Med Biol. 2018. PMID: 29427096 Review.
Huntington disease.
Ghosh R, Tabrizi SJ. Ghosh R, et al. Handb Clin Neurol. 2018;147:255-278. doi: 10.1016/B978-0-444-63233-3.00017-8. Handb Clin Neurol. 2018. PMID: 29325616 Review.
The Prevalence of Huntington's Disease.
Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L. Rawlins MD, et al. Neuroepidemiology. 2016;46(2):144-53. doi: 10.1159/000443738. Epub 2016 Jan 30. Neuroepidemiology. 2016. PMID: 26824438 Free article. Review.
Therapeutic Antisense Targeting of Huntingtin.
Smith AV, Tabrizi SJ. Smith AV, et al. DNA Cell Biol. 2020 Feb;39(2):154-158. doi: 10.1089/dna.2019.5188. Epub 2019 Dec 10. DNA Cell Biol. 2020. PMID: 31821021 Review.
DNA repair in the trinucleotide repeat disorders.
Jones L, Houlden H, Tabrizi SJ. Jones L, et al. Lancet Neurol. 2017 Jan;16(1):88-96. doi: 10.1016/S1474-4422(16)30350-7. Lancet Neurol. 2017. PMID: 27979358 Review.
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Byrne LM, Rodrigues FB, Johnson EB, Wijeratne PA, De Vita E, Alexander DC, Palermo G, Czech C, Schobel S, Scahill RI, Heslegrave A, Zetterberg H, Wild EJ. Byrne LM, et al. Sci Transl Med. 2018 Sep 12;10(458):eaat7108. doi: 10.1126/scitranslmed.aat7108. Sci Transl Med. 2018. PMID: 30209243
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, Zetterberg H, Leavitt BR, Kuhn R, Tabrizi SJ, Macdonald D, Weiss A. Wild EJ, et al. J Clin Invest. 2015 May;125(5):1979-86. doi: 10.1172/JCI80743. Epub 2015 Apr 6. J Clin Invest. 2015. PMID: 25844897 Free PMC article.
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.
McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network. McNulty P, et al. J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263. J Huntingtons Dis. 2018. PMID: 30103338
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Schobel SA, et al. Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142089 Free PMC article. Clinical Trial.
75 results
Jump to page
Feedback